| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Laura Oliphant is Director at AEHR. From April 2020 to August 2026, the filings on record show 0 open-market purchases and 16 sales. Laura Oliphant's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $1.0M at current prices.
Historically, Laura Oliphant's trades have earned a middling insider score of 55/100 across 15 rated trades. Over a 12-month horizon, 58.3% of those trades were profitable, with an average 12-month return of -11.6%.
The AEHR filings lean toward selling, a net 105,988 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 11, 2022 | AEHR Aehr Test Systems | Director | Sell | 6,731 | $25.00 | $168,275.00 | -31.6% | +34.7% | -0.4% | |
| Oct 25, 2022 | AEHR Aehr Test Systems | Director | Sell | 1,083 | $22.04 | $23,873.98 | -4.8% | +59.0% | +43.7% | |
| Oct 24, 2022 | AEHR Aehr Test Systems | Director | Sell | 5,806 | $22.00 | $127,732.00 | -20.6% | +56.6% | +49.9% | |
| Oct 28, 2021 | AEHR Aehr Test Systems | Director | Sell | 11,381 | $21.50 | $244,691.50 | -35.1% | -45.8% | -1.0% | |
| Aug 17, 2021 | AEHR Aehr Test Systems | Director | Sale+OE | 25,000 | $5.30 | $132,540.00 | - | +373.6% | +218.3% | |
| Jul 21, 2021 | AEHR Aehr Test Systems | Director | Sell | 18,456 | $5.75 | $106,122.00 | -37.8% | +147.2% | +51.2% |